Daglutril

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameDaglutril
Drug Alias Namedaglutrilum达格鲁曲daglutrildaglutriloSLV-306 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin-converting enzyme 1 inhibitorsNeprilysin inhibitors
TargetsNeprilysinEndothelin-converting enzyme 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaSlovakiaItaly +[12] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSolvay Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A